# Coya Therapeutics, Inc.: Form 8-K, filed Jun 26, 2025

- Company: [Coya Therapeutics, Inc.](/companies/coya.md) (CIK 1835022)
- Form: 8-K
- Filed: 2025-06-26
- Accepted by EDGAR: Jun 26, 2025, 17:00 ET
- Period: 2025-06-26
- Accession: 0001193125-25-149104
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1835022/000119312525149104/d60996d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1835022/000119312525149104/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1835022/000119312525149104/d60996d8k.htm

Filed Jun 26, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-149104. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.